Ranitidine is one of the antidepressant drug – gaining demand on the account of rising cases of anxiety and depression
Ranitidine, also known as Zantac or Tagamet, is an antidepressant drug that is used to treat patients who suffer from depression and anxiety. It has been found to be effective in the treatment of these disorders by controlling both the physical and psychological reactions associated with them. Ranitidine is available in different forms such as syrup and tablets. The dosage varies according to the specific type of tablet taken.
Ranitidine, despite being an anti-depressant, is not recommended for use in children under the age of 12 because of its potential for causing Nitrosamine Impaired Eyes, or NRI. This condition is caused by prolonged exposure to nitrosamines. Ranitidine was introduced to the market in 1990 and is made in the shape of tablets. Ranitidine, like most other antidepressants, can cause serious side effects in case of prolonged or repeated use.
Ranitidine is manufactured in different batches. The composition of these batches may differ slightly from one another, especially when different ingredients are added to it. There was a recall announced for the batch of Ranitidine containing the ingredient arbutin, which is supposed to be good for the cardiovascular system.
Normally Ranitidine is not habit-forming, but due to its effects on the neurotransmitters responsible for the appetite, it is possible for the patient to become addicted to this medicine. Once addicted to ranitidine, the person develops a tolerance to the drug.
Ranitidine may also be useful for the treatment of gastric ulcers. In addition to the gastric antigens, ranitidine has other potential applications like treating ulcerative colitis, Helicobacter pylori infection, hepatitis, hyperlipoproteinaemia, Renal failure, acute hepatitis, and gallstone problems. Ranitidine is a commonly prescribed pre-operative and post-operative medication in the treatment of gastric ulcers. It can be taken up to 6 months before the surgery.
Comments
Post a Comment